ArticleThe journal of headache and pain2026
EGR1-associated inflammatory and neurovascular signatures suggest a potential link between migraine and ischemic stroke.
Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMigraine is associated with an increased risk of ischemic stroke, but the molecular mechanisms linking these two disorders remain unclear.
methodsWe performed an integrated analysis of bulk RNA-seq data from ischemic stroke and single-cell RNA-seq data from a mouse migraine model. Differential expression, Gene Ontology enrichment, cell-cell communication, protein-protein interaction, disease association, and drug-gene interaction analyses were conducted to identify shared molecular signatures and pathways. A nitroglycerin-induced migraine mouse model was further used to validate neurovascular alterations in vivo.
resultsIntegrated transcriptomic analysis identified shared upregulated genes between migraine and ischemic stroke, with IL1B and EGR1 emerging as key candidates. In ischemic stroke, enriched pathways were mainly related to immune and inflammatory responses, particularly immune response-regulating cell surface receptor signaling and interleukin-1-mediated signaling, with IL1B and EGR1 emerging as prominent candidates in the enriched network context. Single-cell analysis showed that EGR1 was the only significantly shared upregulated gene in migraine, with elevated expression in PEP neurons, NF neurons, vascular cells, and fibroblasts, while the interleukin-1 production pathway was activated in most of these cell types. Cell-cell communication analysis revealed enhanced interactions among neuronal, vascular, and fibroblast populations, especially through ANGPTL signaling. Network analysis highlighted EGR1, IL1B, TLR4, and ANGPTL2 as candidate hub-associated molecules. In vivo, the migraine model showed increased neuronal activation, persistent mechanical hypersensitivity, and reduced ZO-1 expression in the trigeminocervical complex, indicating vascular tight junction impairment.
conclusionThese findings identify shared inflammatory and neurovascular signatures across migraine-related and ischemic stroke-related datasets, with EGR1 emerging as a candidate molecule associated with these convergent changes. Our results support a hypothesis-generating model in which inflammatory signaling and altered neurovascular communication may represent potential links between migraine and stroke-related vascular vulnerability. Further functional studies are required to determine whether EGR1 or related pathways play a causal role.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.